Internal Reference Number: FOI_6723
Date Request Received: 04/08/2022 00:00:00
Date Request Replied To: 31/08/2022 00:00:00
This response was sent via: By Email
Request Summary: Dermatological conditions
Request Category: Companies
Question Number 1: How many patients were treated in last 4 months by the Dermatology department (for any disease) with each of the following: • Abrocitinib • Acitretin • Alitretinoin • Azathioprine • Baricitinib • Ciclosporin • Dupilumab • Methotrexate • Mycophenolate mofetil • Pimecrolimus • Tacrolimus ointment • Tralokinumab • Upadacitinib | |
Answer To Question 1: Abrocitinib 0 Acitretin 29 Alitretinoin 5 Azathioprine <5 Baricitinib 0 Ciclosporin 6 Dupilumab 14 Methotrexate 24 Mycophenolate <5 Pimecrolimus 11 Tacrolimus ointment 30 Tralokinumab 0 Upadacitinib 0 | |
Question Number 2: Of the patients treated in the last 4 months with any of the products listed in Q1, how many patients were paediatric (age 17 or under)? | |
Answer To Question 2: None. | |
Question Number 3: How many patients were treated in the last 4 months with phototherapy (UVB or PUVA) for atopic dermatitis ONLY? | |
Answer To Question 3: 0 patients were treated in the last 4 months with phototherapy for atopic dermatitis only. | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.